首页>
外国专利>
Ophthalmic formulation of vascular endothelial growth factor antagonist, a method of producing the same and syringe suitable for intravitreal administration comprising the same
Ophthalmic formulation of vascular endothelial growth factor antagonist, a method of producing the same and syringe suitable for intravitreal administration comprising the same
展开▼
机译:血管内皮生长因子拮抗剂的眼用制剂,其制备方法和适用于玻璃体内给药的注射器
展开▼
页面导航
摘要
著录项
相似文献
摘要
Ophthalmic formulations of a vascular endothelial growth factor (VEGF)-specific fusion protein antagonist are provided suitable for intravitreal administration to the eye. The ophthalmic formulations include a stable liquid formulation and a lyophilizable formulation. Preferably, the protein antagonist has the amino acid sequence showing in SEQ ID No: 4 or amino acids 27-457 of SEQ ID No: 4.
展开▼
机译:提供了适于眼内玻璃体内给药的血管内皮生长因子(VEGF)特异性融合蛋白拮抗剂的眼科制剂。眼科制剂包括稳定的液体制剂和可冻干的制剂。优选地,蛋白质拮抗剂具有SEQ ID No:4所示的氨基酸序列或SEQ ID No:4的氨基酸27-457。
展开▼